APA (7th ed.) Citation

Kriegsmann, K., Dingeldein, G., Cremer, M., Kriegsmann, M., Ho, A. D., Rieger, M., & Witzens-Harig, M. (2017). Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma. BioMed Central; Springer. https://doi.org/10.1186/s12885-017-3332-3

Chicago Style (17th ed.) Citation

Kriegsmann, Katharina, Günther Dingeldein, Martin Cremer, Mark Kriegsmann, Anthony Dick Ho, Michael Rieger, and Mathias Witzens-Harig. Addition of Rituximab to CHOP-like Chemotherapy in First Line Treatment of Primary Mediastinal B-cell Lymphoma. London; Berlin; Heidelberg: BioMed Central; Springer, 2017. https://doi.org/10.1186/s12885-017-3332-3.

MLA (9th ed.) Citation

Kriegsmann, Katharina, et al. Addition of Rituximab to CHOP-like Chemotherapy in First Line Treatment of Primary Mediastinal B-cell Lymphoma. BioMed Central; Springer, 2017. https://doi.org/10.1186/s12885-017-3332-3.